BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Market News

Recovery hopes brighten as Fuel Cell’s loss eases to record low

The financial performance of Fuel Cell Energy (FCEL), which has been mired in a protracted losing streak, improved in the first quarter. Net loss eased more than estimated and reached a historical low aided by a surge in revenues, led by product sales, and tax-related gains. After the news, shares of the energy solutions provider […]

March 8, 2018 2 min read
Market News

The financial performance of Fuel Cell Energy (FCEL), which has been mired in a protracted losing streak, improved in the first quarter. Net loss eased more than estimated and reached a historical low aided by a surge in revenues, led by product sales, and tax-related gains. After the news, shares of the energy solutions provider […]

The financial performance of Fuel Cell Energy (FCEL), which has been mired in a protracted losing streak, improved in the first quarter.

Net loss eased more than estimated and reached a historical low aided by a surge in revenues, led by product sales, and tax-related gains.

After the news, shares of the energy solutions provider gained more than 4% in early trading hours Thursday.

The company is hopeful that the recent execution of certain legislative bills would help it expand market share, for they are expected to bring significant capital investment to the sector.

“We continue to see favorable momentum in our marketplace, both in U.S. federal policy and with project execution and development. The signing of a PPA with Bolthouse Farms extends our relationship with a long-term customer Campbell Soup Company,” said Fuel Cell CEO Chip Bottone.

First quarter loss narrowed to $0.12 per share from $0.39 per share last year. In addition to strong revenue growth, the bottom line also benefited from an income tax benefit of about $3 million.

Revenues more than doubled to about $39 billion during the quarter, owing primarily to a surge in product sales reflecting completion of deliveries for a utility project to be owned by Korea Southern Power Company.

Commissioning of the project, the installation which is currently progressing, is expected to begin in spring. The plant is scheduled to be operational in late summer.

ADVERTISEMENT